Home > Boards > US Listed > Biotechs > Affimed Therapeutics (AFMD)

https://finance.yahoo.com/news/week-ahead-biotech-conferences-pdufa-163828429.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Dennisb68 Member Profile
Member Level 
Followed By 108
Posts 25,797
Boards Moderated 3
Alias Born 02/03/05
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/23/2020 6:45:15 AM
Affimed Reports First Quarter 2020 Financial Results and Operational Progress GlobeNewswire Inc. - 6/23/2020 6:30:00 AM
Affimed Announces Presentation of Data on Genentech’s RO7297089 and AFM24, Both Innate Cell Engagers Developed from Affimed... GlobeNewswire Inc. - 6/22/2020 9:20:00 AM
Affimed Announces Successful Completion of First Dose Cohort in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of... GlobeNewswire Inc. - 6/17/2020 6:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/16/2020 10:56:13 AM
Affimed to Report First Quarter 2020 Financial Results & Corporate Update June 23, 2020; Company to Participate in Virtual BM... GlobeNewswire Inc. - 6/16/2020 6:30:00 AM
Affimed Announces Appointment of Angus Smith as Chief Financial Officer GlobeNewswire Inc. - 6/11/2020 6:30:00 AM
Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting GlobeNewswire Inc. - 5/29/2020 8:05:00 AM
Affimed to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/28/2020 5:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/26/2020 4:30:57 PM
Affimed Announces Abstracts on Innate Cell Engagers from its ROCK® Platform Accepted for Presentation at AACR Virtual Annual... GlobeNewswire Inc. - 5/15/2020 5:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/13/2020 4:33:10 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/13/2020 4:32:30 PM
Schedule 13g Edgar (US Regulatory) - 5/8/2020 8:10:57 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 4/28/2020 5:04:54 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/28/2020 6:49:07 AM
Affimed Reports 2019 Financial Results and Recent Operational Progress GlobeNewswire Inc. - 4/28/2020 6:35:00 AM
Affimed Announces First Patient Successfully Dosed in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced ... GlobeNewswire Inc. - 4/16/2020 7:30:00 AM
Affimed Provides COVID-19-Related Business Update and Announces Full Year 2019 Financial Results Conference Call on April 28,... GlobeNewswire Inc. - 4/2/2020 6:30:00 AM
Affimed Announces FDA Granted Orphan Drug Designation for Lead Innate Cell Engager AFM13 for the Treatment of T-cell Lymphoma... GlobeNewswire Inc. - 4/1/2020 4:01:00 PM
Affimed Announces Participation at Upcoming Virtual Investor Conferences GlobeNewswire Inc. - 3/26/2020 7:30:00 AM
Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer GlobeNewswire Inc. - 3/17/2020 7:30:00 AM
Affimed to Present at the SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire Inc. - 2/19/2020 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 4:19:26 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/7/2020 8:51:29 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist